A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)

ClinicalTrials.gov ID: NCT02724228

Public ClinicalTrials.gov record NCT02724228. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of BMN 111 in Children With Achondroplasia

Study identification

NCT ID: NCT02724228
Recruitment status: Active, not recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: BioMarin Pharmaceutical; Industry
Enrollment: 30 participants

Conditions and interventions

Conditions

Achondroplasia

Interventions

BMN 111 Drug

Drug

Eligibility (public fields only)

Age range: 7 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 25, 2016
Primary completion: Nov 30, 2027
Completion: Jan 31, 2028
Last update posted: Mar 12, 2026

2016 – 2028

United States locations

U.S. sites: 6
U.S. states: 5
U.S. cities: 6

Facility	City	State	ZIP	Site status
Children's Hospital & Research Center Oakland	Oakland	California	94609	—
Harbor - UCLA Medical Center	Torrance	California	90509	—
Ann and Robert H. Lurie Childrens Hospital of Chicago	Chicago	Illinois	60611	—
Johns Hopkins McKusick - Institute of Genetic Medicine	Baltimore	Maryland	21287	—
Vanderbilt University	Nashville	Tennessee	37232-2578	—
Baylor College of Medicine	Houston	Texas	77030	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02724228, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 12, 2026 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02724228 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →